Anatara Lifesciences logo

ANR - Anatara Lifesciences Share Price

A$0.345 0.0  0.0%

Last Trade - 23/01/20

Sector
Healthcare
Size
Micro Cap
Market Cap £8.90m
Enterprise Value £6.08m
Revenue £440k
Position in Universe 1254th / 1860
Bullish
Bearish
Unlock ANR Revenue
Momentum
Relative Strength (%)
1m
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Margin of Safety
Qualifying GuruScreens
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

ANR Revenue Unlock ANR Revenue

Net Income

ANR Net Income Unlock ANR Revenue

Normalised EPS

ANR Normalised EPS Unlock ANR Revenue

PE Ratio Range

ANR PE Ratio Range Unlock ANR Revenue

Dividend Yield Range

ANR Dividend Yield Range Unlock ANR Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
ANR EPS Forecasts Unlock ANR Revenue
Profile Summary

Anatara Lifesciences Ltd is an Australia-based company focused on developing oral solutions for gastrointestinal diseases in production animals and humans and the development and commercialization of Detach, a non-antibiotic therapy that prevents and treats diarrhea (scour) in piglets. Detach is a modified release formulation of BromelainRx, a natural extract from pineapple stems. Detach helps in address the overuse of antibiotics in animals. It is formulated with various ingredients to allow oral administration and delivery to the small intestine. The Company is focused on developing Detach for pigs in Australia and then expanding the program to Europe and the United States. The Company is also developing a similar version of Detach to prevent diarrhea in humans. The Company is seeking to collaborate with pharmaceutical/biotechnology companies for clinical development and commercialization of a similar version of Detach for human application in travelers and military personnel.

Directors
Last Annual June 30th, 2019
Last Interim June 30th, 2019
Incorporated July 15, 2010
Public Since October 16, 2014
No. of Shareholders: 1,070
No. of Employees: n/a
Sector Healthcare
Industry Biotechnology & Medical Research
Index
Exchange Australian Stock Exchange - SEATS
Shares in Issue 49,413,236
Free Float (0.0%)
Eligible for
ISAs
SIPPs
ANR Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for ANR
Upcoming Events for ANR
Similar to ANR
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.